On June 10, the National Small and Medium-sized Enterprise Stock Transfer System Listing Committee (hereinafter referred to as the “listing committee”) held the first review meeting in 2020 and passed Beijing Yingtai Jiahe Biotechnology Co., Ltd. (hereinafter referred to as “Yingtai Biotechnology”) and Shanghai Airong Software Co., Ltd. (hereinafter referred to as “Airong Software”) applied for the listing of selected layers. In the next step, the application for listing of the selected layers of the above two companies will be submitted to the CSRC for approval.
It is worth mentioning that, on the two rest days of this weekend, the listing committee will continue to hold meetings to consider the selection application for the listing of four companies. Among them, on June 13, to review the listing applications of Ningbo Qiguan Cable Co., Ltd. and Tongxiang (Suzhou) Electronic Material Technology Co., Ltd.; on June 14, to consider the functions of Fujian Longtai Bamboo Home Furnishing Co., Ltd. and Anhui Jiaxian Application for listing of Auxiliary Co., Ltd
The National Stock Conversion Corporation pointed out that as of June 9th, the National Stock Conversion Corporation had accepted the application for the listing of 50 companies’ select tiers and issued to 47 of them Ask for advice. As of now, the average time for select-tier companies from acceptance to issue of the first round of inquiries is only 5.4 trading days.
Yingtai Biology: Plan to raise at least 475 million yuan
According to the public offering statement, Yingtai Biology will start on October 20, 2015. The New Third Board is listed and is currently located on the innovation layer. This time, 100 million shares are planned to be issued with a base price of not less than 4.75 yuan per share, and at least 475 million yuan is planned to be raised. The public offering statement stated that after deducting the issuance costs, Yingtai Biotech’s net proceeds will be invested in projects such as the transformation and upgrading of pesticide original drug products, while repaying 100 million yuan of bank loans.
public offering statement states that Yingtai Biotech is a supplier of agricultural chemical products based on research and development and guided by market demand, mainly engaged in the research and development and production of pesticide original drugs, intermediates and preparation products , Sales and GLP technical services, business in more than 20 countries and regions around the world. 2016 toIn 2018, the company ranked 13th, 12th and 10th in sales revenue of the global agrochemical industry, ranking first in China’s local agrochemical companies.
Public information shows that Yingtai Biotechnology’s annual operating income from 2017 to 2019 exceeds 5 billion yuan, and net profit is about 290 million yuan, 460 million yuan and 2.6 respectively. 100 million yuan.
As of the signing date of the public offering statement (May 31, the same below), Winbond Health directly holds 798,599,500 shares of the company, and holds 15,242,500 through the wholly-owned subsidiary Winbond Healthcare Shares, holding a total of 72.29% of the company’s shares, is the company’s controlling shareholder, and Zhang Songshan is the company’s actual controller. In addition, Beijing Hongtai Jiaye Consulting Center (Limited Partnership) directly holds 59,330,000 shares of the company, accounting for 5.27% of the company’s total share capital.
The public offering statement also pointed out that before this public offering, Yingtai Bio’s public shareholders held 16.31% of the shares. After the offering, the shares issued this time accounted for After 8.16% of the total share capital, the company’s public shareholders hold 23.13%.
Airong Software: plans to raise 140 million yuan to 390 million yuan
The public release statement states that Airong Software was launched on June 9, 2014 It is listed on the New Third Board from now on, and its current level is the innovation level. This time, 8.8 million shares are planned to be issued, with an issue price ranging from 16 yuan/share to 45 yuan/share, with a planned fundraising range of 140 million to 390 million yuan.
AiRong Software pointed out that it intends to invest the raised funds in projects such as the construction of innovation laboratories and marketing systems, while repaying 60 million yuan of bank loans.